Glaucoma drug Rhopressa snags early FDA approval

• Posted on: Dec 19 2017
• By: Saratoga Opthalmology
• Leave a response

Aerie Pharmaceuticals announced that the FDA has approved their once-daily glaucoma drop, Rhopressa, for lowering IOP in patients with open-angle glaucoma or ocular hypertension.
Source: AAO

Posted in: Uncategorized